KaloBios Says Martin Shkreli Terminated as CEO
- Fellow board member Tony Chase also resigned on Thursday
- Shkreli held more than 50 percent of shares as of Nov. 24
KaloBios Fires Martin Shkreli as CEO Following Arrest
This article is for subscribers only.
Martin Shkreli was fired as chief executive officer of KaloBios Pharmaceuticals Inc. following his arrest last week on charges of securities fraud.
Shkreli and Tony Chase also resigned from the board of directors, the drugmaker said Monday in a statement. The company didn’t name Shkreli’s successor.